Navigation Links
Therapeutic Cloning Works in Mice With Parkinson's
Date:3/24/2008

Injecting neurons that were genetic match improved symptoms, avoided rejection

MONDAY, March 24 (HealthDay News) -- Therapeutic cloning successfully treated Parkinson's disease in mice, researchers report.

Using the process to develop dopamine-producing neurons with an identical genetic profile to each mouse being treated allowed scientists to significantly improve the neurological performance of the diseased animals, without provoking any evidence of immune system rejection.

"This is the first time that anyone has done this kind of cloning experiment to show the therapeutic aspect of the process in this customized way," said study author Dr. Viviane Tabar, an associate professor of neurosurgery in the department of neurosurgery at the Memorial Sloan-Kettering Cancer Center in New York City.

The finding -- which has not yet been replicated in human trials -- was published in the March 23 online issue of Nature Medicine.

Parkinson's is a neurodegenerative disorder that severely impairs motor skills and speech. According to the National Parkinson Foundation, 1.5 million Americans suffer from the disease, and men and women over 65 are at the greatest risk of developing the debilitating condition.

The illness is sparked by the breakdown of nerve cells in the brain and a resulting drop in the production of the dopamine -- a chemical key to the proper function of muscles and movement. In recent years, the effort to slow or halt dopamine loss has focused on the promise of therapeutic cloning.

Controversy over the ethical ramifications of cloning has led many researchers to draw a clear distinction between therapeutic cloning and reproductive cloning.

Both processes begin with the removal of the nucleus from a single cell taken from any part of the body of a living adult organism. In the laboratory, this isolated nucleus is then inserted into an egg cell that has been stripped
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
2. Prime Therapeutics Receives TIPPS Certification
3. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
4. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
8. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
9. Prime Therapeutics Announces URAC Accreditation
10. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
11. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapeutic Cloning Works in Mice With Parkinson's
(Date:3/6/2015)... (PRWEB) March 06, 2015 “ Pokemini ” ... which features the latest and coolest mobile applications on the ... expert and host of NewsWatch, conducted the app review and ... game. , Over the last couple of years, mobile ... to the game. For example, Candy Crush allows users to ...
(Date:3/6/2015)... San Jose, California (PRWEB) March 06, 2015 ... cancer is one of the most common forms of ... women worldwide. Breast cancer can be screened through various ... among others. Mammography however remains the gold standard technique ... factors such as cost, time taken for the procedure, ...
(Date:3/6/2015)... New York, New York (PRWEB) March 06, 2015 ... tap dancing’s dazzling days on the grand stage, to the ... Legacy Dancers sparkle throughout with precision toe-tapping numbers and their ... and Karyn Tomczak deliver the rich history of tap dancing ... dance forms to come out of the United States. ...
(Date:3/6/2015)... As the Association of American ... 90,000 doctors by 2025 is updated this week and ... is proactively preparing by analyzing demographics and pursuing viable ... , Several factors including the increasing number of retiring ... the Affordable Care Act and an uneven distribution of ...
(Date:3/6/2015)... 06, 2015 Jvion, the Atlanta-based ... of a Clostridium Difficile (C Diff) predictive use ... Diff use case is the latest in a ... acquired infections, chronic conditions, and individual illnesses. Using ... Diff solution flags at risk individuals to help ...
Breaking Medicine News(10 mins):Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... small capsule-shaped bacteria. The immune cells which help protect us ... in space travellers and it could be something to do ... (JSC) have been studying how immune cells behave in microgravity ... space on astronauts.// ,It has been found that astronauts ...
... approved the first pocket-sized EKG machine, so small ... ambulances, the emergency room - even a possible ... hand-held computer-based medical device, part of a growing ... equipment. ,Electrocardiograms, also called EKGs or ECGs, ...
... will probably be prescribed cholesterol-lowering drugs as a result ... cautions that the effects of those medications in that ... Cholesterol Education Program guidelines, about 15 million Americans between ... considered candidates taking statin group of drugs for ...
... claim that just by looking at a person's face could ... is that smokers age faster than non smokers.A study by ... genes responsible for a skin enzyme that breaks down collagen ... of the skin and maintains the elasticity of the skin. ...
... have devised that each cigarette cuts on average 12 minutes ... the difference in life expectancy between smokers and non-smokers and ... male smoker might consume in a lifetime. ,The researchers, ... expectancy from a major study of the impact of// smoking ...
... after a couple of drinks is a common problem for ... was a mystery until now.It may support the potentialities of ... College of Medicine and the Mayo Clinic in Minnesota say ... accused.// They found, in a study of healthy young adults, ...
Cached Medicine News:Health News:Immune cells halt round in space 2
(Date:3/6/2015)... 6, 2015 Lucerne Biosciences, LLC announced ... of U.S. Patent Application No. 14/464,249 entitled "Method ... features claimed methods of "informing a user" that ... Binge Eating Disorder (,BED,)," including by reference to ... an advertisement," as well as by presentation of ...
(Date:3/5/2015)... DIEGO , March 5, 2015  Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its fourth quarter and full year ... March 16, 2015, before the market opens for ... will host a conference call to discuss the ...
(Date:3/5/2015)... Germany , March 5, 2015 ... and CureVac today announced that the foundation has ... million) in CureVac, a leading clinical-stage biopharmaceutical company ... the agreement, the foundation will also provide separate ... based on CureVac,s proprietary messenger RNA (mRNA) platform. ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4
... TALLAHASSEE, Fla., March 11, 2011 The Florida Society ... latest facts on Oxycodone and Hydrocodone use in the ... available to the public or media.  Oxycodone dispensed in ... 2009 ARCOS report, US Census and FDA.Translation from grams ...
... 2011 Mylan Inc. (Nasdaq: MYL ) ... the company,s credit ratings, including the "Corporate Family Rating," ... Moody,s rating outlook is stable.   According ... trends accomplished through new product launches, a strong global ...
Cached Medicine Technology:Florida Pain Clinic Society: 3.7 Billion Oxycodone Tablets Dispensed in U.S. 2Moody's Upgrades Mylan 2
... CSV- lOOOHGT instrument provides standardized glare testing. It ... test faces for the evaluation of glare disability. ... precisely calibrated to simulate two on-coming halogen car ... The glare level can be adjusted to simulate ...
Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: